| 000 | 01334 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516223723.0 | ||
| 264 | 0 | _c20150914 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1464-410X | ||
| 024 | 7 |
_a10.1111/bju.12867 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSonpavde, Guru | |
| 245 | 0 | 0 |
_aCytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC). _h[electronic resource] |
| 260 |
_bBJU international _cJul 2015 |
||
| 300 |
_a17-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aProstatic Neoplasms, Castration-Resistant _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWang, Christopher G | |
| 700 | 1 | _aGalsky, Matthew D | |
| 700 | 1 | _aOh, William K | |
| 700 | 1 | _aArmstrong, Andrew J | |
| 773 | 0 |
_tBJU international _gvol. 116 _gno. 1 _gp. 17-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bju.12867 _zAvailable from publisher's website |
| 999 |
_c24027889 _d24027889 |
||